[Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].

Psychiatria polska - 1 Jan 2000

Milejski Piotr, Orzechowska-Juzwenko Krystyna, Niewiński Przemysław, Hurkacz Magdalena, Czarnik-Matusewicz Henryk, Leszek Jerzy, Rudzik Jacek, Grotthus Bartosz

Abstract excerpt

AIM: The relationship between genetically determined polymorphic oxidation and acetylation and susceptibility to some disease has aroused much interest. The aim of our study was to evaluate whether patients with Alzheimer's disease differ from healthy persons in their ability to oxidize sparteine and acetylate sulphadimidine as model substance. METHOD: Oxidation and acetylation phenotype were estimated in 20...

Topics

Acetylation
Adult
Aged
Alzheimer Disease
Disease Susceptibility
Female
Humans
Male
Middle Aged
Oxidation-Reduction
Phenotype
Polymorphism, Genetic
Risk Factors
Sparteine
Sulfamethazine

Source

Open in PubMed

Identifiers

PMID: 17598435

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics